|
FR2718964A1
|
|
Use of 5-methoxytryptamine succinic amide as a therapeutic active substance and pharmaceutical composition comprising it.
|
|
FR2709421A1
|
|
Use of benzimidazole derivatives as an agent for stabilizing free radicals derived from chlorpromazine and their therapeutic application.
|
|
FR2626178A1
|
|
Method and apparatus for preparing a drug-containing solute containing free radicals and its therapeutic application
|
|
FR2609987A1
|
|
New amide of 2-aminopyrimidine and tranquillising and antisenescent pharmaceutical compositions containing it
|
|
FR2607705A1
|
|
Device for extracorporeal irradiation of blood
|
|
FR2455037A1
|
|
Methoxy tryptamine succinic amide - having melatonin activity, but administrable parenterally
|
|
FR2454805A1
|
|
Anti:anoxia agents - comprising ethyl butyl acetic acid or -acetamide and/or methyl-(cyclohexane-2) vinyl sulphone
|
|
FR2426473A1
|
|
Treatment of leukaemia by UV irradiation of blood - in presence of a phenothiazine amine as radiation sensitiser
|
|
FR2380299A1
|
|
Hypoglycaemic glucoside cpds. of gallic and ellagic acid - prepd. from pomegranate roots or from glucose and gallic acid chloride
|
